Machine learning predictions based on historical earnings data and price patterns
1-Day Prediction
-0.06%
$22.79
0% positive prob.
5-Day Prediction
-0.33%
$22.73
0% positive prob.
20-Day Prediction
-2.58%
$22.21
0% positive prob.
SEC 8-K filings with transcript text
Aug 5, 2026 · 100% conf.
1D
-0.06%
$22.79
Act: +10.31%
5D
-0.33%
$22.73
Act: +10.68%
20D
-2.58%
$22.21
hct-20260803
FALSE000156103200015610322026-08-032026-08-030001561032us-gaap:CommonClassAMember2026-08-032026-08-030001561032hct:SeriesACumulativeRedeemablePerpetualPreferredStockMember2026-08-032026-08-030001561032hct:SeriesBCumulativeRedeemablePerpetualPreferredStockMember2026-08-032026-08-03
PURSUANT TO SECTION 13 OR 15(d) OF THE
Date of Report (Date of earliest event reported): August 3, 2026
National Healthcare Properties, Inc.
(Exact Name of Registrant as Specified in Charter)
Maryland001-3915338-3888962
(State or other jurisdiction of incorporation)(Commission File Number)(I.R.S. Employer Identification No.)
540 Madison Ave., 27th Floor
New York, NY 10022
(Address, including zip code, of Principal Executive Offices)
Registrant’s telephone number, including area code: (332) 258-8770
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
☐Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Securities registered pursuant to section 12(b) of the Act:
Title of each classTrading Symbol(s)Name of each exchange on which registered
Class A common stock, $0.01 par value per shareNHPThe Nasdaq Global Market
7.375% Series A Cumulative Redeemable Perpetual Preferred Stock, $0.01 par value per shareNHPAPThe Nasdaq Global Market
7.125% Series B Cumulative Redeemable Perpetual Preferred Stock, $0.01 par value per shareNHPBPThe Nasdaq Global Market
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company ☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ¨
Item 1.01. Entry into a Material Definitive Agreement.
On August 3, 2026, National Healthcare Properties, Inc. (the “Company”), National Healthcare Properties Operating Partnership, L.P. (the “Operating Partnership”), as borrower, entered into an Amended and Restated Credit Agreement (the “Credit Agreement”) with Wells Fargo Bank, National Association, as administrative agent, and certain lenders party thereto. The Credit Agreement amends and restates in its entirety the prior credit agreement, dated as of December 11, 2025 (as amended prior to the date of the Credit Agreement, the “Original Credit Agreement”), by and among the Company, the Operating Partnership, Wells Fargo Bank, National Association, as administrative agent, and the lenders party thereto.
The $1.2 billion Credit Agreement provides for (i) a $750 million senior unsecured revolving credit facility (the “Revolving Facility”), increased from $400 million under the Original Credit Agreement, (ii) a $300 million senior unsecured term loan facility (the “Term Loan Facility”), increased from $150 million under the Original Credit Agreement, and (iii) a new $150 million senior unsecured delayed draw term loan facility (the “Delayed Draw Term Loan Facility” and, together with the Revolving Facility and the Term Loan Facility, the “Credit Facilities”), which was added to the Credit Agreement. The Credit Agreement also provides that, subject to customary conditions, including obtaining lender commitments and compliance with the financial maintenance covenants under the Credit Agreement, the Operating Partnership may seek to increase the aggregate lending commitments under the Credit Agreement by up to $1.0 billion, which increased from $450 million under the Original Credit Agreement.
The Operating Partnership currently expects to use borrowings under the Credit Facilities for general corporate and working capital purposes, which may include repayment of indebtedness, real estate acquisitions, development costs and capital expenditures.
Pursuant to the Credit Agreement, the Revolving Facility has an initial maturity date of August 3, 2030. The Term Loan Facility and the Delayed Draw Term Loan Facility have an initial maturity date of August 3, 2029. Each of the Revolving Facility and the Term Loan Facility may be extended, at the Operating Par
May 13, 2026
hct-20260513
FALSE000156103200015610322026-05-132026-05-130001561032us-gaap:CommonClassAMember2026-05-132026-05-130001561032hct:SeriesACumulativeRedeemablePerpetualPreferredStockMember2026-05-132026-05-130001561032hct:SeriesBCumulativeRedeemablePerpetualPreferredStockMember2026-05-132026-05-13
PURSUANT TO SECTION 13 OR 15(d) OF THE
Date of Report (Date of earliest event reported): May 13, 2026
National Healthcare Properties, Inc.
(Exact Name of Registrant as Specified in Charter)
Maryland 001-39153 38-3888962
(State or other jurisdiction of incorporation) (Commission File Number) (I.R.S. Employer Identification No.)
540 Madison Ave., 27th Floor
New York, NY 10022
(Address, including zip code, of Principal Executive Offices)
Registrant’s telephone number, including area code: (332) 258-8770
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
☐Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Securities registered pursuant to section 12(b) of the Act:
Title of each classTrading Symbol(s)Name of each exchange on which registered
Class A common stock, $0.01 par value per shareNHPThe Nasdaq Global Market
7.375% Series A Cumulative Redeemable Perpetual Preferred Stock, $0.01 par value per shareNHPAPThe Nasdaq Global Market
7.125% Series B Cumulative Redeemable Perpetual Preferred Stock, $0.01 par value per shareNHPBPThe Nasdaq Global Market
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company ☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ¨
Item 2.02. Results of Operations and Financial Condition.
National Healthcare Properties, Inc. (the “Company”) issued a press release on May 13, 2026 announcing its financial results for the quarter ended March 31, 2026. A copy of the press release is furnished herewith and attached hereto as Exhibit 99.1. The information in this Item 2.02 and Exhibit 99.1 attached hereto shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that section and shall not be deemed incorporated by reference in any filing made by the Company under the Securities Act of 1933, as amended, or the Exchange Act except as set forth by specific reference in such filing.
Item 9.01. Financial Statements and Exhibits.
(d) Exhibits
Exhibit No.Description
99.1
Press Release of National Healthcare Properties, Inc. dated May 13, 2026
104Cover Page Interactive Data File - the cover page XBRL tags are embedded within the Inline XBRL
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
Date: May 13, 2026 By: /s/ Andrew T. Babin
Andrew T. Babin
Chief Financial Officer and Treasurer
Apr 13, 2026
hct-20260410
FALSE000156103212/3100015610322026-04-102026-04-100001561032hct:SeriesACumulativeRedeemablePerpetualPreferredStockMember2026-04-102026-04-100001561032hct:SeriesBCumulativeRedeemablePerpetualPreferredStockMember2026-04-102026-04-10
PURSUANT TO SECTION 13 OR 15(d) OF THE
Date of Report (Date of earliest event reported): April 10, 2026
National Healthcare Properties, Inc.
(Exact Name of Registrant as Specified in Charter)
Maryland 001-39153 38-3888962
(State or other jurisdiction of incorporation) (Commission File Number) (I.R.S. Employer Identification No.)
540 Madison Ave., 27th Floor
New York, NY 10022
(Address, including zip code, of Principal Executive Offices)
Registrant’s telephone number, including area code: (332) 258-8770
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
☐Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Securities registered pursuant to section 12(b) of the Act:
Title of each classTrading Symbol(s)Name of each exchange on which registered
7.375% Series A Cumulative Redeemable Perpetual Preferred Stock, $0.01 par value per shareNHPAPThe Nasdaq Global Market
7.125% Series B Cumulative Redeemable Perpetual Preferred Stock, $0.01 par value per shareNHPBPThe Nasdaq Global Market
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company ☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ¨
Item 2.02. Results of Operations and Financial Condition.
Information regarding quarterly results of National Healthcare Properties, Inc. (the “Company”) included under Item 7.01 of this Current Report on Form 8-K is incorporated by reference herein. The information in this Item 2.02 shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that section and shall not be incorporated by reference in any filing of the Company under the Securities Act of 1933, as amended (the “Securities Act”), or the Exchange Act except as set forth by specific reference in such filing.
Item 5.03 Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year.
On April 10, 2026, the Company filed Articles Supplementary with the State Department of Assessments and Taxation of Maryland, providing for the authorization of up to 100,000,000 shares of Class A common stock, par value $0.01 per share (the “Class A common stock”). The Class A common stock has been authorized in connection with the Company’s proposed public offering of Class A common stock (the “Offering”). The terms of the Class A common stock are identical to the terms of the Company’s common stock, except that each share of Class A common stock will automatically convert into one share of common stock 180 days after the pricing of the Offering, if completed.
The foregoing summary of the Articles Supplementary is qualified in its entirety by reference to the full text of the Articles Supplementary, a copy of which is filed as Exhibit 3.1 to this Current Report on Form 8-K, and incorporated by reference herein.
Item 7.01. Regulation FD Disclosure.
Preliminary Estimates for the Quarter Ended March 31, 2026
Based on the Company’s preliminary estimates as of the date of this Current Report on Form 8-K, management currently expects to report the following for the quarter ended March 31, 2026:
For the Company’s senior housing operating properties (“SHOP”) segment, on a same store basis:
•Average occupancy of approximately 83.8% for the quarter ended March 31, 2026, as compared to 84.6% for the quarter ended December 31, 2025 and 81.0% for the quarter ended March 31, 2025;
•Revenue per occupied room (RevPOR) of between $6,275 and $6,325 for the quarter ended March 31, 2026, as compared to $6,107 for the quarter ended December 31, 2025 and $6,071 for the quarter
This page provides National Healthcare Properties Inc. 7.125% Series B Cumulative Redeemable Perpetual Preferred Stock (NHPBP) earnings call transcripts from SEC 8-K filings along with AI-powered predictions for post-earnings price movements. Our machine learning models analyze historical earnings data, pre-earnings price patterns, volume changes, and volatility to predict 1-day, 5-day, and 20-day returns after each earnings release.
Earnings transcripts are sourced directly from SEC EDGAR filings. Predictions are generated using gradient boosting models trained on NHPBP's historical earnings reactions. All predicted returns are shown as percentages, and predicted prices are calculated from the closing price at the time of prediction. Past performance does not guarantee future results.